FDA Issues Public Health Advisory on Chantix, Which May Become the Subject of Product Liability Suits
The U.S. Food and Drug Administration (FDA) on February 1, 2008, issued a Public Health Advisory to alert health care providers, patients, and caregivers to new safety warnings concerning Chantix (varenicline), a prescription medication used to help patients stop smoking. Serious neuropsychiatric symptoms have occurred in patients taking Chantix. These symptoms include changes in behavior, agitation, depressed mood, suicidal ideation, and attempted and completed suicide. Chantix has been suggested as being a possibly significant contributing factor to the bizarre and tragic death of musician Carter Albrecht on September 5, 2007. The FDA action adds credibility to the belief that Chantix is a dangerous product and may spur attorneys reviewing potential cases to institute litigation. The FDA is issuing this Alert to highlight important revisions t